Purepac warning letter
Executive Summary
Good manufacturing practices problems at Purepac's Elizabeth, N.J. facility are resolved, Faulding says, following FDA reinspection of the plant. FDA cited GMP deviations related to the plant in an April 9 warning letter. Alpharma is in the process of acquiring Purepac (1"The Pink Sheet" July 16, p. 21)